Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerich, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerich, J. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:S117-S121, 2002
© 2002 by the American Diabetes Association, Inc.


Section 3: Phasic Insulin Release and Metabolic Control

Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?

John E. Gerich

From the Department of Medicine, University of Rochester, Rochester, New York

Insulin is released from the pancreas in a biphasic manner in response to a square-wave increase in arterial glucose concentration. The first phase consists of a brief spike lasting ~10 min followed by the second phase, which reaches a plateau at 2–3 h. It is widely thought that diminution of first-phase insulin release is the earliest detectable defect of ß-cell function in individuals destined to develop type 2 diabetes and that this defect largely represents ß-cell exhaustion after years of compensation for antecedent insulin resistance. In this article, the origins of these concepts are reviewed and recent evidence is presented suggesting that reductions in both phases of insulin release are equally early, that they precede insulin resistance other than that simply due to obesity, and that they therefore may represent the primary genetic risk factor predisposing individuals to type 2 diabetes.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biophys. JHome page
Y.-d. Chen, S. Wang, and A. Sherman
Identifying the Targets of the Amplifying Pathway for Insulin Secretion in Pancreatic {beta}-Cells by Kinetic Modeling of Granule Exocytosis
Biophys. J., September 1, 2008; 95(5): 2226 - 2241.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
T. Rose, S. Efendic, and M. Rupnik
Ca2+-Secretion Coupling Is Impaired in Diabetic Goto Kakizaki rats
J. Gen. Physiol., June 1, 2007; 129(6): 493 - 508.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
P. E. MacDonald and P. Rorsman
The Ins and Outs of Secretion from Pancreatic {beta}-Cells: Control of Single-Vesicle Exo- and Endocytosis
Physiology, April 1, 2007; 22(2): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Hoenig, K. Thomaseth, M. Waldron, and D. C. Ferguson
Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R227 - R234.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Lu, T. Ventura-Holman, J. Li, R. W. McMurray, J. S. Subauste, and J. F. Maher
Abnormal Glucose Homeostasis and Pancreatic Islet Function in Mice with Inactivation of the Fem1b Gene
Mol. Cell. Biol., August 1, 2005; 25(15): 6570 - 6577.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. G. Straub and G. W. G. Sharp
Hypothesis: one rate-limiting step controls the magnitude of both phases of glucose-stimulated insulin secretion
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C565 - C571.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
M. K Jayapaul and M. Walker
Review: Mechanisms contributing to the development of type 2 diabetes
The British Journal of Diabetes & Vascular Disease, July 1, 2004; 4(4): 227 - 231.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
F. Ashcroft and P. Rorsman
Type 2 diabetes mellitus: not quite exciting enough?
Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R21 - R31.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Hagen, J. Hjelmesaeth, T. Jenssen, L. Morkrid, and A. Hartmann
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2154 - 2159.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Uusitupa, V. Lindi, A. Louheranta, T. Salopuro, J. Lindstrom, and J. Tuomilehto
Long-Term Improvement in Insulin Sensitivity by Changing Lifestyles of People with Impaired Glucose Tolerance: 4-Year Results From the Finnish Diabetes Prevention Study
Diabetes, October 1, 2003; 52(10): 2532 - 2538.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Suzuki, M. Fukushima, M. Usami, M. Ikeda, A. Taniguchi, Y. Nakai, T. Matsuura, A. Kuroe, K. Yasuda, T. Kurose, et al.
Factors Responsible for Development From Normal Glucose Tolerance to Isolated Postchallenge Hyperglycemia
Diabetes Care, April 1, 2003; 26(4): 1211 - 1215.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.